MNOV (MediciNova, Inc.) Stock Financials & Earnings | Market Cap Arena

MNOV (MediciNova, Inc.) Stock Financials & Earnings | Market Cap Arena

MNOVMediciNova, Inc.

Mkt Cap$69M

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Revenue (TTM)$409,657

Net Income (TTM)-$12M

EPS (TTM)-$0.24

Free Cash Flow (TTM)-$10M

Gross Margin7.6%

Op. Margin-3242.5%

Net Margin-2928.8%

FCF Margin-2394.7%

P/S Ratio (TTM)169.2x

P/E Ratio (TTM)—

YoY Rev Growth—

Employees—

Earnings Reports

Revenue & Profitability

Quarter	Revenue	Gross Profit	Op. Income
Q1 23	$0	$0	-$3M
Q2 23	$0	$0	-$3M
Q3 23	$1M	$1M	-$1M
Q4 23	$0	-$5K	-$2M
Q1 24	$0	$0	-$3M
Q2 24	$0	$0	-$3M
Q3 24	$0	$0	-$3M
Q4 24	$0	-$5K	-$3M
Q1 25	$0	$0	-$3M
Q2 25	$135K	$18K	-$4M
Q3 25	$123K	-$39K	-$3M
Q4 25	$152K	$52K	-$3M

Valuation

Quarter	P/S	P/E
Q1 23	—	—
Q2 23	—	—
Q3 23	69.3x	—
Q4 23	69.3x	—
Q1 24	69.3x	—
Q2 24	69.3x	—
Q3 24	—	—
Q4 24	—	—
Q1 25	—	—
Q2 25	514.8x	—
Q3 25	268.7x	—
Q4 25	169.2x	—

Operating Cash Flow

Quarter	Operating CF	Free CF
Q1 23	-$3M	-$3M
Q2 23	-$2M	-$2M
Q3 23	-$1M	-$1M
Q4 23	-$499K	-$499K
Q1 24	-$4M	-$4M
Q2 24	-$3M	-$3M
Q3 24	-$2M	-$2M
Q4 24	-$2M	-$2M
Q1 25	-$4M	-$4M
Q2 25	-$2M	-$2M
Q3 25	-$2M	-$2M
Q4 25	-$2M	-$2M

Capital Expenditures

CapEx

Quarter	CapEx
Q1 23	$0
Q2 23	$19K
Q3 23	$3K
Q4 23	$22
Q1 24	$0
Q2 24	$891
Q3 24	$6
Q4 24	$2
Q1 25	$0
Q2 25	$0
Q3 25	$3K
Q4 25	$3K

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q1 23	—	-13.1%
Q2 23	—	-19.3%
Q3 23	—	-44.9%
Q4 23	—	-22.9%
Q1 24	—	+5.8%
Q2 24	—	-7.7%
Q3 24	-100.0%	+54.1%
Q4 24	—	+27.9%
Q1 25	—	+2.1%
Q2 25	—	+22.8%
Q3 25	—	+5.9%
Q4 25	—	+1.9%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q1 23	$403K	—
Q2 23	$326K	—
Q3 23	$219K	21.9%
Q4 23	-$237K	—
Q1 24	$215K	—
Q2 24	$207K	—
Q3 24	$505K	—
Q4 24	$264K	—
Q1 25	$286K	—
Q2 25	$205K	152.2%
Q3 25	$0	0.0%
Q4 25	$338K	222.9%

OpEx Breakdown

Quarter	R&D	G&A	S&M	SG&A
Q1 23	$1M	$1M	$66K	—
Q2 23	$2M	$2M	$64K	—
Q3 23	$702K	$1M	$64K	—
Q4 23	$2M	—	—	$839K
Q1 24	$2M	$1M	$63K	—
Q2 24	$2M	$1M	$62K	—
Q3 24	$2M	$1M	$74K	—
Q4 24	$2M	$1M	—	—
Q1 25	$2M	$1M	$55K	—
Q2 25	$2M	$1M	—	—
Q3 25	$2M	—	—	$2M
Q4 25	$2M	$2M	—	—

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 23	$55M	$0	$55M
Q2 23	$53M	$0	$53M
Q3 23	$52M	$0	$52M
Q4 23	$51M	$0	$51M
Q1 24	$47M	$0	$47M
Q2 24	$44M	$0	$44M
Q3 24	$42M	$0	$42M
Q4 24	$40M	$0	$40M
Q1 25	$37M	$0	$37M
Q2 25	$34M	$0	$34M
Q3 25	$33M	$0	$33M
Q4 25	$31M	$0	$31M

Shares Outstanding

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change
Q1 23	49M	+0.0%
Q2 23	49M	+0.0%
Q3 23	49M	+0.0%
Q4 23	49M	+0.0%
Q1 24	49M	+0.0%
Q2 24	49M	+0.0%
Q3 24	49M	+0.0%
Q4 24	49M	+0.0%
Q1 25	49M	+0.0%
Q2 25	49M	+0.0%
Q3 25	49M	+0.0%
Q4 25	49M	+0.0%

Revenue Per Employee

Revenue / Employee

Year	Revenue/Employee	Employees
FY 14	$0	10
FY 15	$0	10
FY 16	$0	10
FY 17	$0	9
FY 18	$0	9
FY 19	$0	8
FY 20	$0	9
FY 21	$367K	11
FY 22	$0	13
FY 23	$77K	13
FY 24	$0	13
FY 25	$32K	13